Novel Drug Delivery Technologies

IRISYS develops formulations for new chemical entities and ANDA/generic products. We also have experience developing formulations with 505(b)(2) product candidates, which can rely in part on data from existing reference drugs. Our formulations can support the expansion of our clients’ intellectual property portfolios.

Micronization technologies

  • Microparticles
  • Nanoparticles

Encapsulation technologies

  • Liposomes
  • Microspheres
  • Micelles

Controlled release formulations

  • Solid oral
  • Liquid oral
  • Topical

For more information about our Novel Drug Delivery Technologies services, fill out the contact form below: